Table 3  Numbers (percentages) of subjects who were seroprotected at two and six months after vaccination (intention to treat analysis)

Month
Antigen (µg) No of subjects 2 6

5 25 5 (20) 1 (4)
10 25 3 (12) 6 (24)
20 25 8 (32) 10 (40)
40 25 11 (44) 9 (36)
Total 100 27 (27) 26 (26)
Odds ratio for a doubling in dose of vaccine (95% confidence interval) 1.63 (1.07 to 2.49) 1.87 (1.20 to 2.92)
P value 0.02 0.006